USCA RIA’s ContraFect Corporation CFRX Stock Holding History

USCA RIA’s Portfolio CFRX Stock Details CFRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-181	Closed	-$73K	–	565
2020 Q4	$73K	Sell	181 -10	-5%	-$4.33K	0.01%	479
2020 Q3	$81K	Buy	+191	New	+$86.6K	0.01%	448

Other funds holding CFRX

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

MCM

Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

USCA RIA's CFRX Position: Q1 2021 in Review

USCA RIA sold out of ContraFect Corporation (CFRX) in Q1 2021, closing a stake of 181 shares — an estimated $73K sold.

USCA RIA first reported a position in CFRX in Q3 2020 and held it in 2 quarters. The position peaked at $81K in Q3 2020. 80 funds tracked by Wall St. Rank hold CFRX as of Q1 2021.

USCA RIA reported no remaining ContraFect Corporation position as of Q1 2021 after selling out during the quarter.
USCA RIA sold 181 ContraFect Corporation shares in Q1 2021, an estimated $73K.
USCA RIA first reported a position in ContraFect Corporation in Q3 2020 and held it in 2 quarters.
USCA RIA's ContraFect Corporation position peaked at $81K in Q3 2020.
80 funds tracked by Wall St. Rank held ContraFect Corporation as of Q1 2021.

Based on USCA RIA's 13F filing for Q1 2021, filed 27 Apr 2021.